カテゴリ： QYResearch, 世界, 医療/バイオ

関節リウマチ検査の世界市場2025年：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他

■ 英語タイトル：Global Rheumatoid Arthritis Testing Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6789）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6789
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[関節リウマチ検査の世界市場2025年：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は関節リウマチ検査のグローバル市場について調査・分析し、世界の関節リウマチ検査市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他）、用途別セグメント分析（病院/診断センター、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott Laboratories、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthineers、Augurex Life Sciences、Svar Life Science AB、Aviva Systems Biology、Bio-Rad Laboratories、Thermo Fisher Scientific、Microdrop、Werfen、Axis-Shieldなどが含まれています。関節リウマチ検査のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、関節リウマチ検査市場規模を算出する際に考慮しました。

・関節リウマチ検査市場の概要
- 関節リウマチ検査の種類別セグメント
- 世界の関節リウマチ検査市場規模：タイプ別分析（血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他）
- 関節リウマチ検査の用途別セグメント
- 世界の関節リウマチ検査市場規模：用途別分析（病院/診断センター、クリニック、その他）
- 世界の関節リウマチ検査市場規模予測（2020年-2031年）

・関節リウマチ検査市場の成長トレンド
- 関節リウマチ検査の地域別市場規模（2020年-2031年）
- 関節リウマチ検査市場ダイナミクス
- 関節リウマチ検査の業界動向
- 関節リウマチ検査市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他
- 世界の関節リウマチ検査のタイプ別市場規模（2020年-2025年）
- 世界の関節リウマチ検査のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院/診断センター、クリニック、その他
- 世界の関節リウマチ検査の用途別市場規模（2020年-2025年）
- 世界の関節リウマチ検査の用途別市場規模（2024年-2029年）

・関節リウマチ検査の地域別市場規模
- 北米の関節リウマチ検査市場規模（2020年-2031年）
- 米国の関節リウマチ検査市場規模（2020年-2031年）
- ヨーロッパの関節リウマチ検査市場規模（2020年-2031年）
- アジア太平洋の関節リウマチ検査市場規模（2020年-2031年）
- 中国の関節リウマチ検査市場規模（2020年-2031年）
- 日本の関節リウマチ検査市場規模（2020年-2031年）
- 韓国の関節リウマチ検査市場規模（2020年-2031年）
- インドの関節リウマチ検査市場規模（2020年-2031年）
- オーストラリアの関節リウマチ検査市場規模（2020年-2031年）
- 中南米の関節リウマチ検査市場規模（2020年-2031年）
- 中東・アフリカの関節リウマチ検査市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Abbott Laboratories、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthineers、Augurex Life Sciences、Svar Life Science AB、Aviva Systems Biology、Bio-Rad Laboratories、Thermo Fisher Scientific、Microdrop、Werfen、Axis-Shield

・アナリストの観点/結論

・調査手法と情報源

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
Highlights
The global Rheumatoid Arthritis Testing market was valued at US$ 2318.3 million in 2024 and is anticipated to reach US$ 3487 million by 2031, witnessing a CAGR of 7.0% during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Testing.
The Rheumatoid Arthritis Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rheumatoid Arthritis Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatoid Arthritis Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Serological Tests
1.2.3 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
1.2.4 Imaging Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Testing Market Perspective (2020-2031)
2.2 Rheumatoid Arthritis Testing Growth Trends by Region
2.2.1 Global Rheumatoid Arthritis Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rheumatoid Arthritis Testing Historic Market Size by Region (2020-2025)
2.2.3 Rheumatoid Arthritis Testing Forecasted Market Size by Region (2026-2031)
2.3 Rheumatoid Arthritis Testing Market Dynamics
2.3.1 Rheumatoid Arthritis Testing Industry Trends
2.3.2 Rheumatoid Arthritis Testing Market Drivers
2.3.3 Rheumatoid Arthritis Testing Market Challenges
2.3.4 Rheumatoid Arthritis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Testing Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis Testing Players by Revenue (2020-2025)
3.1.2 Global Rheumatoid Arthritis Testing Revenue Market Share by Players (2020-2025)
3.2 Global Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis Testing Revenue
3.4 Global Rheumatoid Arthritis Testing Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Testing Revenue in 2022
3.5 Rheumatoid Arthritis Testing Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis Testing Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Testing Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Testing Historic Market Size by Type (2020-2025)
4.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2026-2031)
5 Rheumatoid Arthritis Testing Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Testing Historic Market Size by Application (2020-2025)
5.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rheumatoid Arthritis Testing Market Size (2020-2031)
6.2 North America Rheumatoid Arthritis Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rheumatoid Arthritis Testing Market Size by Country (2020-2025)
6.4 North America Rheumatoid Arthritis Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Testing Market Size (2020-2031)
7.2 Europe Rheumatoid Arthritis Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rheumatoid Arthritis Testing Market Size by Country (2020-2025)
7.4 Europe Rheumatoid Arthritis Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size (2020-2031)
8.2 Asia-Pacific Rheumatoid Arthritis Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Testing Market Size (2020-2031)
9.2 Latin America Rheumatoid Arthritis Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rheumatoid Arthritis Testing Market Size by Country (2020-2025)
9.4 Latin America Rheumatoid Arthritis Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size (2020-2031)
10.2 Middle East & Africa Rheumatoid Arthritis Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Rheumatoid Arthritis Testing Introduction
11.3.4 Beckman Coulter Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.3.5 Beckman Coulter Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Introduction
11.4.4 Siemens Healthineers Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.4.5 Siemens Healthineers Recent Development
11.5 Augurex Life Sciences
11.5.1 Augurex Life Sciences Company Detail
11.5.2 Augurex Life Sciences Business Overview
11.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Introduction
11.5.4 Augurex Life Sciences Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.5.5 Augurex Life Sciences Recent Development
11.6 Svar Life Science AB
11.6.1 Svar Life Science AB Company Detail
11.6.2 Svar Life Science AB Business Overview
11.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Introduction
11.6.4 Svar Life Science AB Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.6.5 Svar Life Science AB Recent Development
11.7 Aviva Systems Biology
11.7.1 Aviva Systems Biology Company Detail
11.7.2 Aviva Systems Biology Business Overview
11.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Introduction
11.7.4 Aviva Systems Biology Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.7.5 Aviva Systems Biology Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Microdrop
11.10.1 Microdrop Company Detail
11.10.2 Microdrop Business Overview
11.10.3 Microdrop Rheumatoid Arthritis Testing Introduction
11.10.4 Microdrop Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.10.5 Microdrop Recent Development
11.11 Werfen
11.11.1 Werfen Company Detail
11.11.2 Werfen Business Overview
11.11.3 Werfen Rheumatoid Arthritis Testing Introduction
11.11.4 Werfen Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.11.5 Werfen Recent Development
11.12 Axis-Shield
11.12.1 Axis-Shield Company Detail
11.12.2 Axis-Shield Business Overview
11.12.3 Axis-Shield Rheumatoid Arthritis Testing Introduction
11.12.4 Axis-Shield Revenue in Rheumatoid Arthritis Testing Business (2020-2025)
11.12.5 Axis-Shield Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Serological Tests
Table 3. Key Players of Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Table 4. Key Players of Imaging Tests
Table 5. Key Players of Others
Table 6. Global Rheumatoid Arthritis Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Rheumatoid Arthritis Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Rheumatoid Arthritis Testing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Rheumatoid Arthritis Testing Market Share by Region (2020-2025)
Table 10. Global Rheumatoid Arthritis Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Rheumatoid Arthritis Testing Market Share by Region (2026-2031)
Table 12. Rheumatoid Arthritis Testing Market Trends
Table 13. Rheumatoid Arthritis Testing Market Drivers
Table 14. Rheumatoid Arthritis Testing Market Challenges
Table 15. Rheumatoid Arthritis Testing Market Restraints
Table 16. Global Rheumatoid Arthritis Testing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Rheumatoid Arthritis Testing Market Share by Players (2020-2025)
Table 18. Global Top Rheumatoid Arthritis Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2022)
Table 19. Ranking of Global Top Rheumatoid Arthritis Testing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Rheumatoid Arthritis Testing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Rheumatoid Arthritis Testing Product Solution and Service
Table 23. Date of Enter into Rheumatoid Arthritis Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rheumatoid Arthritis Testing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Rheumatoid Arthritis Testing Revenue Market Share by Type (2020-2025)
Table 27. Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Rheumatoid Arthritis Testing Revenue Market Share by Type (2026-2031)
Table 29. Global Rheumatoid Arthritis Testing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Rheumatoid Arthritis Testing Revenue Market Share by Application (2020-2025)
Table 31. Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Rheumatoid Arthritis Testing Revenue Market Share by Application (2026-2031)
Table 33. North America Rheumatoid Arthritis Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Rheumatoid Arthritis Testing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Rheumatoid Arthritis Testing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Rheumatoid Arthritis Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Rheumatoid Arthritis Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Rheumatoid Arthritis Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Rheumatoid Arthritis Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Rheumatoid Arthritis Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Rheumatoid Arthritis Testing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Rheumatoid Arthritis Testing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Rheumatoid Arthritis Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Rheumatoid Arthritis Testing Product
Table 51. Abbott Laboratories Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. F. Hoffmann-La Roche Company Detail
Table 54. F. Hoffmann-La Roche Business Overview
Table 55. F. Hoffmann-La Roche Rheumatoid Arthritis Testing Product
Table 56. F. Hoffmann-La Roche Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 57. F. Hoffmann-La Roche Recent Development
Table 58. Beckman Coulter Company Detail
Table 59. Beckman Coulter Business Overview
Table 60. Beckman Coulter Rheumatoid Arthritis Testing Product
Table 61. Beckman Coulter Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 62. Beckman Coulter Recent Development
Table 63. Siemens Healthineers Company Detail
Table 64. Siemens Healthineers Business Overview
Table 65. Siemens Healthineers Rheumatoid Arthritis Testing Product
Table 66. Siemens Healthineers Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 67. Siemens Healthineers Recent Development
Table 68. Augurex Life Sciences Company Detail
Table 69. Augurex Life Sciences Business Overview
Table 70. Augurex Life Sciences Rheumatoid Arthritis Testing Product
Table 71. Augurex Life Sciences Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 72. Augurex Life Sciences Recent Development
Table 73. Svar Life Science AB Company Detail
Table 74. Svar Life Science AB Business Overview
Table 75. Svar Life Science AB Rheumatoid Arthritis Testing Product
Table 76. Svar Life Science AB Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 77. Svar Life Science AB Recent Development
Table 78. Aviva Systems Biology Company Detail
Table 79. Aviva Systems Biology Business Overview
Table 80. Aviva Systems Biology Rheumatoid Arthritis Testing Product
Table 81. Aviva Systems Biology Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 82. Aviva Systems Biology Recent Development
Table 83. Bio-Rad Laboratories Company Detail
Table 84. Bio-Rad Laboratories Business Overview
Table 85. Bio-Rad Laboratories Rheumatoid Arthritis Testing Product
Table 86. Bio-Rad Laboratories Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 87. Bio-Rad Laboratories Recent Development
Table 88. Thermo Fisher Scientific Company Detail
Table 89. Thermo Fisher Scientific Business Overview
Table 90. Thermo Fisher Scientific Rheumatoid Arthritis Testing Product
Table 91. Thermo Fisher Scientific Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 92. Thermo Fisher Scientific Recent Development
Table 93. Microdrop Company Detail
Table 94. Microdrop Business Overview
Table 95. Microdrop Rheumatoid Arthritis Testing Product
Table 96. Microdrop Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 97. Microdrop Recent Development
Table 98. Werfen Company Detail
Table 99. Werfen Business Overview
Table 100. Werfen Rheumatoid Arthritis Testing Product
Table 101. Werfen Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 102. Werfen Recent Development
Table 103. Axis-Shield Company Detail
Table 104. Axis-Shield Business Overview
Table 105. Axis-Shield Rheumatoid Arthritis Testing Product
Table 106. Axis-Shield Revenue in Rheumatoid Arthritis Testing Business (2020-2025) & (US$ Million)
Table 107. Axis-Shield Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatoid Arthritis Testing Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Rheumatoid Arthritis Testing Market Share by Type: 2022 VS 2029
Figure 3. Serological Tests Features
Figure 4. Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests Features
Figure 5. Imaging Tests Features
Figure 6. Others Features
Figure 7. Global Rheumatoid Arthritis Testing Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 8. Global Rheumatoid Arthritis Testing Market Share by Application: 2022 VS 2029
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Rheumatoid Arthritis Testing Report Years Considered
Figure 13. Global Rheumatoid Arthritis Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Rheumatoid Arthritis Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Rheumatoid Arthritis Testing Market Share by Region: 2022 VS 2029
Figure 16. Global Rheumatoid Arthritis Testing Market Share by Players in 2024
Figure 17. Global Top Rheumatoid Arthritis Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Testing Revenue in 2024
Figure 19. North America Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Rheumatoid Arthritis Testing Market Share by Country (2020-2031)
Figure 21. United States Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Rheumatoid Arthritis Testing Market Share by Country (2020-2031)
Figure 25. Germany Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Rheumatoid Arthritis Testing Market Share by Region (2020-2031)
Figure 33. China Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Rheumatoid Arthritis Testing Market Share by Country (2020-2031)
Figure 41. Mexico Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Rheumatoid Arthritis Testing Market Share by Country (2020-2031)
Figure 45. Turkey Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Rheumatoid Arthritis Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 49. Beckman Coulter Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 50. Siemens Healthineers Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 51. Augurex Life Sciences Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 52. Svar Life Science AB Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 53. Aviva Systems Biology Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 56. Microdrop Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 57. Werfen Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 58. Axis-Shield Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

※参考情報

関節リウマチ（RA）は、自己免疫疾患の一種で、主に関節に炎症を引き起こし、痛み、腫れ、運動制限を伴う慢性的な状態です。世界中で多くの人々がこの病気に悩まされており、特に中年女性に多く見られます。関節リウマチの診断には様々な検査が行われ、悩ましい症状を管理し、患者の生活の質を向上させるための重要な手段です。

関節リウマチの検査の目的は明確であり、疾患の早期発見と診断、病状の進行状況の評価、治療効果のモニタリングが求められます。診断が遅れると、関節の変形や機能障害が進行する可能性があるため、迅速な対応が求められます。

関節リウマチに関連する検査は、主に以下の2つのカテゴリーに分けることができます。第一に、血液検査、第二に、画像検査です。

血液検査は、関節リウマチの診断において非常に重要な役割を果たします。最も一般的な血液検査には、リウマトイド因子（RF）や抗CCP抗体（抗環状シトルリン化ペプチド抗体）が含まれます。リウマトイド因子は、関節リウマチの患者の約70%で陽性となりますが、他の疾患でも陽性結果が得られることがあるため、単独では確定診断には至りません。一方、抗CCP抗体は、より特異的なマーカーとされ、関節リウマチの診断において非常に有用です。

また、炎症の指標として、C反応性タンパク質（CRP）や赤血球沈降速度（ESR）も評価されます。これらの値が高い場合、体内で何らかの炎症が起こっていることを示唆しますが、特定の疾患に結びつけることはできません。そのため、これらの検査結果は症状や他の検査と合わせて総合的に解釈する必要があります。

次に画像検査ですが、これにはX線、超音波検査、磁気共鳴画像法（MRI）が使用されます。X線は、関節の骨に対する影響を評価するために広く用いられています。早期のRAでは、主に腫れや骨の侵食が見られるため、X線検査を通じて関節の状態を確認することができます。ただし、RAの初期段階ではX線での異常が現れにくいため、他の検査と組み合わせて行うことが重要です。

超音波検査は、関節内の炎症や滑膜の肥厚をリアルタイムで評価できるため、非常に有用です。この検査は痛みを伴わず、複数の関節を一度に評価できるため、特に診断の初期段階や治療効果のモニタリングに役立ちます。また、MRIは、関節の軟部組織の評価や、早期発見のための有用なツールとして活用されています。関節の構造的変化や骨髄浮腫を詳しく観察できるため、RAの診断において重要です。

関節リウマチの検査は、診断だけでなく、治療のモニタリングにも用いられます。治療開始後、定期的な血液検査や画像検査を通じて、患者の分析が行われ、治療効果や副作用を評価します。治療の選択肢には、非ステロイド性抗炎症薬（NSAIDs）、病気修飾抗リウマチ薬（DMARDs）、生物学的製剤などがあり、これらを適切に組み合わせて使用することが重要です。

最近では、マイクロRNAやタンパク質の解析による新しいバイオマーカーの研究も進んでいます。これにより、より個別化された治療戦略の立案が期待されており、今後の発展が注目されています。

関節リウマチの検査技術は日々進化しており、診断精度の向上や治療への応用が期待されています。医療の発展に伴い、より早期に正確な診断ができるようになれば、患者のQOL（生活の質）の向上につながるでしょう。今後は、これらの技術がより多くの患者に利用され、関節リウマチとの闘いに勝利する手助けとなることが期待されます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 呼吸器疾患検査のグローバル市場（2023～2030）：画像検査、呼吸計、血液ガス検査
  • 世界の非侵襲性癌診断市場2022年ｰ2031年：検査タイプ別（尿検査、画像検査、分光検査）
  • 世界の肝炎診断検査市場予測2024年-2032年：検査種類別（血液検査、画像検査、肝生検）、地域別
  • 狂犬病診断の世界市場（2022年～2032年）：蛍光抗体検査、免疫組織化学検査、増幅法、組織学的検査、血清学的検査
  • 世界のライム病検査市場（2024年~2030年）：技術別（IGRA検査）、検査別（血清学的検査、核酸検査）、サンプル別（血液、尿）、用途別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6789 )"関節リウマチ検査の世界市場2025年：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他" (英文：Global Rheumatoid Arthritis Testing Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。